Discrepancy remains in pharmaceutical prescriptions in four European countries

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7163.947 (Published 03 October 1998) Cite this as: BMJ 1998;317:947
  1. Silvio Garattini, Director,
  2. Livio Garattini, Director.
  1. Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
  2. Centro di Economia Sanitaria “A. Valenti” (CESAV) Ranica (BG), Italy

    EDITOR—Several years ago we reported the drugs that had been most widely sold by value in four countries in Europe (France, Germany, Italy, and the United Kingdom) in 1992.1 We report here the drug sales in the same countries in 1996.

    We firstly established how many of the 50 products that were most widely sold in the four countries did not have appropriate documentation of efficacy. In France, Germany, and Italy …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription